Daewoong Pharmaceutical Co. Ltd.

This phase 2 trial tests whether an experimental drug called DWN12088 can safely slow the decline in lung function for people with idiopathic pulmonary fibrosis (IPF), a progressive lung-scarring disease. About 102 adults aged 40 and older with stable IPF will be randomly assigne…

This study is looking at whether enavogliflozin, a diabetes medication, can help people with type 2 diabetes lose weight. Researchers will track 200 adults over 24 weeks in regular doctor visits. The main goal is to see changes in body weight and BMI, along with safety.

This study is observing 15,000 adults with type 2 diabetes who are starting Envlo or Envlomet SR tablets. Researchers will check how well these drugs control blood sugar (HbA1c) over 24 weeks and monitor for side effects. The goal is to see if they work safely in everyday medical…

This study tests whether a smartphone app called WellCheck, linked to patients' electronic health records, can improve blood sugar, blood pressure, and weight in people with type 2 diabetes. About 471 adults will use the app either with their doctor's guidance or on their own. Th…